XML 22 R10.htm IDEA: XBRL DOCUMENT
v3.25.1

Share Transactions | 3 Months Ended
--- | ---
Mar. 31, 2025
Stockholders' Equity Note [Abstract] |
Share transactions | Share-Based Compensation During the 2025 first quarter, the Company granted 0.4 million stock options, 0.5 million performance share awards and performance share units (“PSAs/PSUs”) and 0.7 million restricted shares and units to certain employees. The stock options were valued at the grant date using the Black-Scholes option pricing model. The weighted average grant-date fair value of the stock options, PSAs/PSUs and restricted shares and units granted during the 2025 first quarter were $32.46, $93.26 and $91.87 per share, respectively. Such values are being amortized over the respective substantive vesting period, inclusive of retirement eligible features. During the 2024 first quarter, the Company granted 0.4 million stock options, 0.5 million performance share awards and performance share units PSAs/PSUs and 0.7 million restricted shares and units to certain employees. The stock options were valued at the grant date using the Black-Scholes option pricing model. The weighted average grant-date fair value of the stock options, PSAs/PSUs and restricted shares and units granted during the 2024 first quarter were $30.73, $93.28 and $87.22 per share, respectively. Such values are being amortized over the respective substantive vesting period, inclusive of retirement eligible features. Share Repurchases The Board of Directors of Arch Capital has authorized the investment in Arch Capital’s common shares through a share repurchase program. Since the inception of the share repurchase program, Arch Capital has repurchased 436.0 million common shares for an aggregate purchase price of $6.1 billion. For the three months ended March 31, 2025, Arch Capital repurchased 2.2 million shares under the share repurchase program with an aggregate purchase price of $196.4 million. Arch Capital did not repurchase any shares under the share repurchase program during the three months ended March 31, 2024. At March 31, 2025, $800.4 million of share repurchases were available under the program, which may be effected from time to time in open market or privately negotiated transactions. The timing and amount of the repurchase transactions under this program will depend on a variety of factors, including market conditions and corporate and regulatory considerations.

X
- Definition The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP). + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718/tableOfContent Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 505 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/505/tableOfContent + Details
Name: | us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration